Clinical Trials

Head & Neck Cancer Trials

Protocol   PSHCI#   P.I.   Title Status/Date
PSHCI-14-031   RTOG 1221; STUDY00000430   Mackley, Heath   Randomized Phase II Trial of Transoral Endoscopic Head And Neck Surgery followed by Risk-Based IMRT and Weekly Cisplatin versus IMRT and Weekly Cisplatin for HPV Negative Oropharynx Cancer SRC/PSC APPROVAL 04/22/2014
PSHCI-15-037   STUDY00002500   Warrick, Joshua, Irl   Molecular Characterization of Squamous Dysplasia in the Head and Neck SRC/PSC APPROVAL 05/07/2015
PSHCI-15-040       Goldenberg, David   Molecular Analysis for Classification of Morphologically Indeterminate Thyroid Tumors SRC/PSC APPROVAL 05/22/2015
PSHCI-10-030   33198   Goldenberg, David   Pigmentation of Papillary Thyroid Carcinoma Lymph Node Metastases OPEN TO ACCRUAL 04/12/2010
PSHCI-11-010   33502ep   Goldenberg, David   Head and Neck Cells: Tissue Repository OPEN TO ACCRUAL 01/04/2012
PSHCI-13-058   44274CI-CIRB;
RTOG 1216
  Almokadem, Salah   Randomized Phase II/III Trial of Surgery and Postoperative Radiation Delivered with Concurrent Cisplatin versus Docetaxel versus Docetaxel and Cetuximab for High-Risk Squamous Cell Cancer of the Head and Neck
OPEN TO ACCRUAL 02/20/2014
PSHCI-13-061   44674; VRXP-A202   Almokadem, Salah  
A Randomized, Double-Blind, Placebo-Controlled Study of Chemotherapy
Plus Cetuximab in Combination with VTX-2337 in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
OPEN TO ACCRUAL 03/31/2014
  IRB #00000760; STUDY00000760   Goldenberg, David   Comparison of Preoperative Fine Needle Aspiration Biopsy Results to Final Pathology in Thyroid Nodules of Varying Sizes OPEN TO ACCRUAL 08/28/2014
PSHCI-14-006   E3311; STUDY00000169   Mackley, Heath   Phase II Randomized Trial of Transoral Surgical Resection followed by Low-dose or Standard-dose IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer FA SIGNOFF 06/04/2014
PSHCI-14-066   1740; MK-3475-040   Almokadem, Salah   A Phase 3 Trial of Pembrolizumab (MK-3475) vs Standard Treatment in Recurrent/Metastatic Head and Neck Cancer FA SIGNOFF 06/05/2015